Press release
June 4, 2026
LeonaBio Presents on ATH-1105 at 5th Annual ALS Drug Development Summit
LeonaBio, Inc. (LONA)
Introduces brelgometon as the International Nonproprietary Name (INN) for ATH-1105 BOTHELL, Wash., June 04, 2026 (GLOBE NEWSWIRE) -- LeonaBio, Inc. (NASDAQ: LONA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical